Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Donor KIR genotype based outco...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight

Optimizing natural killer (NK) cell alloreactivity could further improve outcome after allogeneic hematopoietic cell transplantation (alloHCT). The donor’s Killer-cell Immunoglobulin-like Receptor (KIR) genotype may provide important information in this regard. In the past decade, different models h...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Jorinde D. Hoogenboom, Stephen R. Spellman, Alexander Kulagin, Thomas Schroeder, Henrik Sengeloev, Peter Dreger, Edouard Forcade, Jan Vydra, Eva Maria Wagner-Drouet, Goda Choi, Shankara Paneesha, Nuno A. A. Miranda, Alina Tanase, Liesbeth C. de Wreede, Vinzenz Lange, Alexander H. Schmidt, Jürgen Sauter, Joshua A. Fein, Yung-Tsi Bolon, Meilun He, Steven G. E. Marsh, Shahinaz M. Gadalla, Sophie Paczesny, Annalisa Ruggeri, Christian Chabannon, Katharina Fleischhauer
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Subjects:
killer-cell immunoglobulin-like receptor (KIR)
allogeneic hematopoietic cell transplantation (alloHCT)
risk of relapse
donor selection
prediction model
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1350470/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1350470/full

Similar Items

  • Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study
    by: Elke Rücker-Braun, et al.
    Published: (2025-06-01)
  • Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity
    by: Johannes Schetelig, et al.
    Published: (2021-07-01)
  • Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation
    by: Lidan Zhu, et al.
    Published: (2022-05-01)
  • Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy
    by: Jun Zou, et al.
    Published: (2022-10-01)
  • Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation – the Karolinska experience
    by: Olle Ringdén, et al.
    Published: (2024-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs